Sel Hardy and Shams Afzal bring the health care sector into focus. Shams sees no shortage of headwinds, including tariffs and the government’s attempts to lower drug prices. He still sees upside on Eli Lilly (LLY), though. Sel is looking long-term and tracking obesity and oncology, which she expects to continue to grow. She also thinks Eli Lilly is well positioned.
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe
Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185
Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7
Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch
Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore
Watch on DistroTV - https://www.distro.tv/live/schwab-network/
Follow us on X – https://twitter.com/schwabnetwork
Follow us on Facebook – https://www.facebook.com/schwabnetwork
Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/
About Schwab Network - https://schwabnetwork.com/about
Fler avsnitt av Schwab Network
Visa alla avsnitt av Schwab NetworkSchwab Network med Schwab Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
